Avita Medical (ASX:AVH) published clinical results that showed two patients with complex full-thickness hand wounds treated with its collagen-based dermal matrix, Cohealyx, achieved autograft readiness within days, rather than the weeks seen with existing dermal matrices, according to a Thursday statement by the company.
One patient showed a well-vascularized wound bed by day five and received an autograft by day seven, while the second patient achieved robust revascularization by day 10 and underwent grafting on day 13, the company said.
Revascularization is the restoration of blood supply to a tissue or organ.
Both showed strong wound bed vascularization and successful graft take, the company added.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。